Show Summary Details
Page of

Percutaneous interventions for congenital heart disease in adults 

Percutaneous interventions for congenital heart disease in adults
Chapter:
Percutaneous interventions for congenital heart disease in adults
Author(s):

Jozef Mašura

DOI:
10.1093/med/9780199558872.003.0011
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 11 July 2020

Percutaneous closure of congenital shunts (atrial septal defect (ASD) secundum type, foramen ovale patents, ventricular septal defect (VSD), and patent ductus arteriosus (PDA)) is feasible using modern implantable devices (e.g. Amplatzer occluders).

Short-term results are excellent, long-term data comparing the outcomes with surgical treatment are not yet available.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.